PKCθ utility in diagnosing c-KIT/DOG-1 double negative gastrointestinal stromal tumors

Attila Kövecsi, Ioan Jung, Z. Szentirmay, Tivadar Bara, Tivadar Bara, Daniel Popa, Simona Gurzu

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: The aim of this study was to evaluate the diagnosis value of an immunohistochemical (IHC) panel of three antibodies for the diagnosis of gastrointestinal stromal tumors (GISTs). Material and methods: In 80 consecutive GISTs without lymph node metastases, the IHC examinations were performed using the antibodies CD117 (c-KIT), DOG-1 and c-theta (PKCθ) protein. The diagnostic value of PKCθ in c-KIT/DOG-1 negative GISTs has been explored in fewer than 10 Medline-indexed papers. Results: The c-KIT, PKCθ and DOG-1 positivity was noted in 92.50% (n = 74), 90% (n = 72) and 76.25% (n = 61) of the cases, respectively. All of the C-KIT negative cases (n = 6) were also DOG-1 negative but displayed PKCθ positivity. All of the DOG-1 positive cases (n = 61) also expressed c-KIT. No correlation between the examined markers and clinicopathological parameters was noted. Conclusions: The PKCθ sensitivity is similar to c-KIT and superior to DOG- 1 sensitivity. All of the c-KIT/DOG-1 negative GISTs seem to express PKCθ. For a proper diagnosis of GIST, the c-KIT/DOG-1/PKCθ panel should be used, with possible therapeutic but not prognostic value.

Original languageEnglish
Pages (from-to)55950-55957
Number of pages8
JournalOncotarget
Volume8
Issue number34
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Gastrointestinal Stromal Tumors
Antibodies
Lymph Nodes
Neoplasm Metastasis
Proteins

Keywords

  • c-theta
  • CD117
  • Diagnosis
  • GIST
  • Pathology section
  • Protein kinase

ASJC Scopus subject areas

  • Oncology

Cite this

PKCθ utility in diagnosing c-KIT/DOG-1 double negative gastrointestinal stromal tumors. / Kövecsi, Attila; Jung, Ioan; Szentirmay, Z.; Bara, Tivadar; Bara, Tivadar; Popa, Daniel; Gurzu, Simona.

In: Oncotarget, Vol. 8, No. 34, 01.01.2017, p. 55950-55957.

Research output: Contribution to journalArticle

Kövecsi, A, Jung, I, Szentirmay, Z, Bara, T, Bara, T, Popa, D & Gurzu, S 2017, 'PKCθ utility in diagnosing c-KIT/DOG-1 double negative gastrointestinal stromal tumors', Oncotarget, vol. 8, no. 34, pp. 55950-55957. https://doi.org/10.18632/oncotarget.19116
Kövecsi, Attila ; Jung, Ioan ; Szentirmay, Z. ; Bara, Tivadar ; Bara, Tivadar ; Popa, Daniel ; Gurzu, Simona. / PKCθ utility in diagnosing c-KIT/DOG-1 double negative gastrointestinal stromal tumors. In: Oncotarget. 2017 ; Vol. 8, No. 34. pp. 55950-55957.
@article{6f58d95addc74495a164c9758e82e599,
title = "PKCθ utility in diagnosing c-KIT/DOG-1 double negative gastrointestinal stromal tumors",
abstract = "Background: The aim of this study was to evaluate the diagnosis value of an immunohistochemical (IHC) panel of three antibodies for the diagnosis of gastrointestinal stromal tumors (GISTs). Material and methods: In 80 consecutive GISTs without lymph node metastases, the IHC examinations were performed using the antibodies CD117 (c-KIT), DOG-1 and c-theta (PKCθ) protein. The diagnostic value of PKCθ in c-KIT/DOG-1 negative GISTs has been explored in fewer than 10 Medline-indexed papers. Results: The c-KIT, PKCθ and DOG-1 positivity was noted in 92.50{\%} (n = 74), 90{\%} (n = 72) and 76.25{\%} (n = 61) of the cases, respectively. All of the C-KIT negative cases (n = 6) were also DOG-1 negative but displayed PKCθ positivity. All of the DOG-1 positive cases (n = 61) also expressed c-KIT. No correlation between the examined markers and clinicopathological parameters was noted. Conclusions: The PKCθ sensitivity is similar to c-KIT and superior to DOG- 1 sensitivity. All of the c-KIT/DOG-1 negative GISTs seem to express PKCθ. For a proper diagnosis of GIST, the c-KIT/DOG-1/PKCθ panel should be used, with possible therapeutic but not prognostic value.",
keywords = "c-theta, CD117, Diagnosis, GIST, Pathology section, Protein kinase",
author = "Attila K{\"o}vecsi and Ioan Jung and Z. Szentirmay and Tivadar Bara and Tivadar Bara and Daniel Popa and Simona Gurzu",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.19116",
language = "English",
volume = "8",
pages = "55950--55957",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "34",

}

TY - JOUR

T1 - PKCθ utility in diagnosing c-KIT/DOG-1 double negative gastrointestinal stromal tumors

AU - Kövecsi, Attila

AU - Jung, Ioan

AU - Szentirmay, Z.

AU - Bara, Tivadar

AU - Bara, Tivadar

AU - Popa, Daniel

AU - Gurzu, Simona

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: The aim of this study was to evaluate the diagnosis value of an immunohistochemical (IHC) panel of three antibodies for the diagnosis of gastrointestinal stromal tumors (GISTs). Material and methods: In 80 consecutive GISTs without lymph node metastases, the IHC examinations were performed using the antibodies CD117 (c-KIT), DOG-1 and c-theta (PKCθ) protein. The diagnostic value of PKCθ in c-KIT/DOG-1 negative GISTs has been explored in fewer than 10 Medline-indexed papers. Results: The c-KIT, PKCθ and DOG-1 positivity was noted in 92.50% (n = 74), 90% (n = 72) and 76.25% (n = 61) of the cases, respectively. All of the C-KIT negative cases (n = 6) were also DOG-1 negative but displayed PKCθ positivity. All of the DOG-1 positive cases (n = 61) also expressed c-KIT. No correlation between the examined markers and clinicopathological parameters was noted. Conclusions: The PKCθ sensitivity is similar to c-KIT and superior to DOG- 1 sensitivity. All of the c-KIT/DOG-1 negative GISTs seem to express PKCθ. For a proper diagnosis of GIST, the c-KIT/DOG-1/PKCθ panel should be used, with possible therapeutic but not prognostic value.

AB - Background: The aim of this study was to evaluate the diagnosis value of an immunohistochemical (IHC) panel of three antibodies for the diagnosis of gastrointestinal stromal tumors (GISTs). Material and methods: In 80 consecutive GISTs without lymph node metastases, the IHC examinations were performed using the antibodies CD117 (c-KIT), DOG-1 and c-theta (PKCθ) protein. The diagnostic value of PKCθ in c-KIT/DOG-1 negative GISTs has been explored in fewer than 10 Medline-indexed papers. Results: The c-KIT, PKCθ and DOG-1 positivity was noted in 92.50% (n = 74), 90% (n = 72) and 76.25% (n = 61) of the cases, respectively. All of the C-KIT negative cases (n = 6) were also DOG-1 negative but displayed PKCθ positivity. All of the DOG-1 positive cases (n = 61) also expressed c-KIT. No correlation between the examined markers and clinicopathological parameters was noted. Conclusions: The PKCθ sensitivity is similar to c-KIT and superior to DOG- 1 sensitivity. All of the c-KIT/DOG-1 negative GISTs seem to express PKCθ. For a proper diagnosis of GIST, the c-KIT/DOG-1/PKCθ panel should be used, with possible therapeutic but not prognostic value.

KW - c-theta

KW - CD117

KW - Diagnosis

KW - GIST

KW - Pathology section

KW - Protein kinase

UR - http://www.scopus.com/inward/record.url?scp=85029055802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029055802&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.19116

DO - 10.18632/oncotarget.19116

M3 - Article

AN - SCOPUS:85029055802

VL - 8

SP - 55950

EP - 55957

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 34

ER -